Abeona Therapeutics (ABEO) CCO discloses 254,608 shares and stock options

Rhea-AI Filing Summary

Abeona Therapeutics’ Chief Commercial Officer, Madhav Vasanthavada, has reported his initial beneficial ownership in the company’s stock. He directly holds 254,608 shares of common stock, which include 176,384 shares of unvested restricted stock scheduled to vest on various dates between January 21, 2026 and January 21, 2028.

He also holds an employee stock option to purchase 2,400 shares of common stock at an exercise price of $4.00 per share, expiring on June 15, 2032. This option became exercisable as to 600 shares on June 15, 2023 and then in 36 equal monthly installments thereafter, providing a gradual vesting schedule over time.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vasanthavada Madhav

(Last) (First) (Middle)

6555 CARNEGIE AVE, 4TH FLOOR

(Street)

CLEVELAND OH 44103

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
ABEONA THERAPEUTICS INC. [ ABEO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	254,608(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(2)	06/15/2032	Common Stock	2,400	$4	D

Explanation of Responses:

1. Includes 176,384 shares of unvested restricted stock, which vest on various dates between January 21, 2026 and January 21, 2028.

2. The option becomes exercisable as to 600 shares on June 15, 2023, and in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Madhav Vasanthavada	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider position does Madhav Vasanthavada hold at Abeona Therapeutics (ABEO)?

Madhav Vasanthavada is reported as an officer of Abeona Therapeutics Inc., serving as the company’s Chief Commercial Officer.

How many Abeona Therapeutics (ABEO) common shares does the CCO beneficially own?

The Chief Commercial Officer beneficially owns 254,608 shares of Abeona Therapeutics common stock, including a significant portion as unvested restricted stock.

How many unvested restricted Abeona (ABEO) shares are included in the CCO’s holdings?

The reported common stock holdings include 176,384 shares of unvested restricted stock, which vest on various dates between January 21, 2026 and January 21, 2028.

What stock options does the Abeona (ABEO) Chief Commercial Officer hold?

He holds an employee stock option to buy 2,400 shares of Abeona common stock at an exercise price of $4.00 per share, expiring on June 15, 2032.

What is the vesting schedule for the Abeona (ABEO) CCO’s stock option?

The option became exercisable for 600 shares on June 15, 2023 and then continues to vest in 36 equal monthly installments after that date.

Is the Abeona (ABEO) CCO’s ownership reported as direct or indirect?

Both the 254,608 common shares and the option for 2,400 shares are reported as held with direct ownership.